Alex Haro - 01 Dec 2025 Form 4 Insider Report for Life360, Inc. (LIF)

Role
Director
Signature
/s/ Jay Sood, as Attorney-in-Fact
Issuer symbol
LIF
Transactions as of
01 Dec 2025
Transactions value $
-$7,644,505
Form type
4
Filing time
01 Dec 2025, 21:41:38 UTC
Previous filing
02 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Haro Alex Director C/O LIFE360, INC., 1900 SOUTH NORFOLK STREET, SUITE 310, SAN MATEO /s/ Jay Sood, as Attorney-in-Fact 01 Dec 2025 0001932626

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIF Common Stock Sale -$3.64M -47.9K -4.98% $75.95 913K 01 Dec 2025 Direct F1, F2
transaction LIF Common Stock Sale -$4.01M -52.1K -5.71% $76.90 861K 01 Dec 2025 Direct F2, F3
holding LIF Common Stock 1.89K 01 Dec 2025 Held by ICCA Labs, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $75.42 to $76.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
F2 Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.42 to $77.37, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
F4 The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.